IT IS AN ANALYTIC, CUASI-EXPERIMENTAL, BEFORE & AFTER KIND STUDY, LONGITUDINAL AND PROSPECTIVE. IT INCLUDES A GROUP OF 23 PATIENTS BETWEEN THE 30 AND 60 YEARS, WITH GLUCOSE ANOMALIES AND OTHER COMORBIDITY, AND THAT WILL BE CALLED NUATIN FROM NOW…